Quick Answer
CHINA PHARMA HOLDINGS, INC. reported Operating Income of -$4.59 million for fiscal year 2024.
CHINA PHARMA HOLDINGS, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$4.59M | -66.8% |
| 2023 | -$2.75M | +22.5% |
| 2022 | -$3.55M | -24.1% |
| 2021 | -$2.86M | -10.9% |
| 2020 | -$2.58M | +87.4% |
| 2019 | -$20.41M | -95.3% |
| 2018 | -$10.45M | +44.1% |
| 2017 | -$18.68M | -129.0% |
| 2016 | -$8.16M | +43.0% |
| 2015 | -$14.30M | +63.1% |
| 2014 | -$38.76M | -108.3% |
| 2013 | -$18.61M | -415.1% |
| 2012 | $5.91M | -73.2% |
| 2011 | $22.03M | -10.7% |
| 2010 | $24.66M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$628.1K | +42.1% | +3.7% |
| June 30, 2025 | -$652.1K | +53.1% | +14.0% |
| March 31, 2025 | -$758.6K | +17.2% | +30.1% |
| September 30, 2024 | -$1.09M | -52.1% | +22.0% |
| June 30, 2024 | -$1.39M | -205.0% | -51.9% |
| March 31, 2024 | -$916.1K | -130.5% | -28.4% |
| September 30, 2023 | -$713.5K | -3.6% | -56.4% |
| June 30, 2023 | -$456.3K | +41.5% | -14.8% |
- CHINA PHARMA HOLDINGS, INC. showed a decrease of -66.8% in Operating Income compared to the prior fiscal year.
- Over the 2010–2024 period, CHINA PHARMA HOLDINGS, INC.’s operating income has declined by 118.6% (from $24.66 million to -$4.59 million).
- The most recent figure is from CHINA PHARMA HOLDINGS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: